Structure of a Human Monoclonal Antibody in Complex with Outer Surface Protein C of the Lyme Disease Spirochete, Borreliella burgdorferi.
Michael J RudolphYang ChenClint VorauerDavid J VanceCarol Lyn PiazzaGraham G WillseyKathleen McCarthyBeatrice MuriukiLisa A CavaciniMiklos GuttmanNicholas J MantisPublished in: Journal of immunology (Baltimore, Md. : 1950) (2024)
Lyme disease is a tick-borne, multisystem infection caused by the spirochete Borreliella burgdorferi. Although Abs have been implicated in the resolution of Lyme disease, the specific B cell epitopes targeted during human infections remain largely unknown. In this study, we characterized and defined the structural epitope of a patient-derived bactericidal monoclonal IgG (B11) against outer surface protein C (OspC), a homodimeric lipoprotein necessary for B. burgdorferi tick-mediated transmission and early-stage colonization of vertebrate hosts. High-resolution epitope mapping was accomplished through hydrogen deuterium exchange-mass spectrometry and X-ray crystallography. Structural analysis of B11 Fab-OspCA complexes revealed the B11 Fabs associated in a 1:1 stoichiometry with the lateral faces of OspCA homodimers such that the Abs are essentially positioned perpendicular to the spirochete's outer surface. B11's primary contacts reside within the membrane-proximal regions of α-helices 1 and 6 and adjacent loops 5 and 6 in one OspCA monomer. In addition, B11 spans the OspCA dimer interface, engaging opposing α-helix 1', α-helix 2', and loop 2-3' in the second OspCA monomer. The B11-OspCA structure is reminiscent of the recently solved mouse transmission blocking monoclonal IgG B5 in complex with OspCA, indicating a mode of engagement with OspC that is conserved across species. In conclusion, we provide a detailed insight into the interaction between a functional human Ab and an immunodominant Lyme disease Ag long considered an important vaccine candidate.
Keyphrases
- high resolution
- monoclonal antibody
- endothelial cells
- mass spectrometry
- early stage
- induced pluripotent stem cells
- pluripotent stem cells
- magnetic resonance imaging
- squamous cell carcinoma
- social media
- radiation therapy
- computed tomography
- quantum dots
- minimally invasive
- multiple myeloma
- drug delivery
- protein protein
- sentinel lymph node
- neoadjuvant chemotherapy
- binding protein